Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Time to see the light.
Axonal transport analysis using Multitemporal Association Tracking.
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.
Structural Insights from Binding Poses of CCR2 and CCR5 with Clinically Important Antagonists: A Combined In Silico Study.
▼Dimethyl fumarate for relapsing-remitting multiple sclerosis.
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
Oral fingolimod (FTY720) for relapsing multiple sclerosis.
Epstein-Barr virus Peptide Presented by HLA-E is Predominantly Recognized by CD8(bright) Cells in multiple Sclerosis Patients.
Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
Multiple sclerosis and sexual dysfunction.
Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes.
Revisiting brain atrophy and its relationship to disability in multiple sclerosis.
The potential for new therapeutic approaches: Global research collaboration examines multiple pathways of neuroprotection in Huntington disease
Trial watch: Chemotherapy with immunogenic cell death inducers.
Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis.
Clinically isolated syndromes and the relationship to multiple sclerosis.
Distinctive structural and functional MRI footprint for cognitive dysfunction in pediatric MS?
A signal-to-noise-ratio-based analysis of multifocal visual-evoked potentials in multiple sclerosis risk assessment.
B-57The Temporal Onset of Cognitive Fatigue in Multiple Sclerosis.
No Association Between Conventional Brain MR Imaging and Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis.
Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases.
1,25-Dihydroxyvitamin D3 Facilitates M2 Polarization and Upregulates TLR10 Expression on Human Microglial Cells.
The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MS.
Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients.
Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System.
Pages
« first
‹ previous
…
138
139
140
141
142
143
144
145
146
…
next ›
last »